281 related articles for article (PubMed ID: 23336348)
41. Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis.
Cheripelli BK; Huang X; MacIsaac R; Muir KW
Stroke; 2016 Jul; 47(7):1761-7. PubMed ID: 27301943
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis.
Orset C; Haelewyn B; Allan SM; Ansar S; Campos F; Cho TH; Durand A; El Amki M; Fatar M; Garcia-Yébenes I; Gauberti M; Grudzenski S; Lizasoain I; Lo E; Macrez R; Margaill I; Maysami S; Meairs S; Nighoghossian N; Orbe J; Paramo JA; Parienti JJ; Rothwell NJ; Rubio M; Waeber C; Young AR; Touzé E; Vivien D
Stroke; 2016 May; 47(5):1312-1318. PubMed ID: 27032444
[TBL] [Abstract][Full Text] [Related]
43. Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.
Olindo S; Chardonnet M; Renou P; Coignion C; Debruxelles S; Poli M; Sagnier S; Rouanet F; Sibon I
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):454-459. PubMed ID: 29128327
[TBL] [Abstract][Full Text] [Related]
44. Thrombolysis for acute ischaemic stroke.
Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
[TBL] [Abstract][Full Text] [Related]
45. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
[TBL] [Abstract][Full Text] [Related]
46. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
[TBL] [Abstract][Full Text] [Related]
47. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
[TBL] [Abstract][Full Text] [Related]
48. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
Edwards NJ; Kamel H; Josephson SA
Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
[TBL] [Abstract][Full Text] [Related]
49. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
[TBL] [Abstract][Full Text] [Related]
50. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
Ma H; Parsons MW; Christensen S; Campbell BC; Churilov L; Connelly A; Yan B; Bladin C; Phan T; Barber AP; Read S; Hankey GJ; Markus R; Wijeratne T; Grimley R; Mahant N; Kleinig T; Sturm J; Lee A; Blacker D; Gerraty R; Krause M; Desmond PM; McBride SJ; Carey L; Howells DW; Hsu CY; Davis SM; Donnan GA;
Int J Stroke; 2012 Jan; 7(1):74-80. PubMed ID: 22188854
[TBL] [Abstract][Full Text] [Related]
51. Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial.
Michel P; Ntaios G; Reichhart M; Schindler C; Bogousslavsky J; Maeder P; Meuli R; Wintermark M
Neuroradiology; 2012 Jun; 54(6):579-88. PubMed ID: 21808985
[TBL] [Abstract][Full Text] [Related]
52. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke.
Qureshi AI; Ali Z; Suri MF; Kim SH; Shatla AA; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
Neurosurgery; 2001 Jul; 49(1):41-8; discussion 48-50. PubMed ID: 11440458
[TBL] [Abstract][Full Text] [Related]
53. [Thrombolysis by intravenous tissue plasminogen activator (t-PA)--current status and future direction].
Tanahashi N
Brain Nerve; 2009 Jan; 61(1):41-52. PubMed ID: 19177806
[TBL] [Abstract][Full Text] [Related]
54. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
[TBL] [Abstract][Full Text] [Related]
55. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study.
Sen S; Huang DY; Akhavan O; Wilson S; Verro P; Solander S
Neurocrit Care; 2009; 11(1):76-81. PubMed ID: 19277904
[TBL] [Abstract][Full Text] [Related]
56. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
[TBL] [Abstract][Full Text] [Related]
57. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
[TBL] [Abstract][Full Text] [Related]
58. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
[TBL] [Abstract][Full Text] [Related]
59. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
[TBL] [Abstract][Full Text] [Related]
60. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
